Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jean-Rémi Garbay"'
Autor:
Amal Ghouadni, Françoise Rimareix, Catherine Uzan, Marie-Christine Mathieu, Philippe Vielh, Sandy Azoulay, Chafika Mazouni, Hélène Caron, Isabelle Borget, Fabrice Andre, Sandra Canale, Diane Boinon, Barbara Pistilli, Muriel Mons, Clarisse Dromain, Nicolas Leymarie, Monica Arnedos, El-Hadi Bayou, Rachel Fontenay, Suzette Delaloge, Jean-Rémi Garbay, Mahasti Saghatchian, Benjamin Sarfati, Voichita Suciu, Corinne Balleyguier, Julia Bonastre, Bruno Boyer, Sofia Rivera, Julia Arfi-Rouche
Publikováno v:
European Journal of Cancer. 66:131-137
Purpose Rapid diagnosis is a key issue in modern oncology, for which one-stop breast clinics are a model. We aimed to assess the diagnosis accuracy and procedure costs of a large-scale one-stop breast clinic. Patients and methods A total of 10,602 in
Autor:
Julia Bonastre, Francoise Callonnec, Sonia Zilberman, I. Jaffré, Claire Chapellier, Nicole Guérin, Philippe Rauch, Marguerite Kandel, Jean-Rémi Garbay, Gilles Houvenaeghel, Pascal Cherel, Ariane Dunant, Marie-Christine Mathieu, Françoise Rimareix, Philippe Henrot, Chafika Mazouni, Ines Raoust, Aurélie Jalaguier, Isabelle Doutriaux-Dumoulin, Marie-Pierre Chauvet, Luc Ceugnart, Corinne Balleyguier, Jocelyne Chopier
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(11)
PURPOSE We evaluated the addition of breast magnetic resonance imaging (MRI) to standard radiologic evaluation on the re-intervention rate in women with ductal carcinoma in situ (DCIS) undergoing breast-conserving surgery. PATIENTS AND METHODS Women
Autor:
Benjamin Sarfati, Dounia Skalli-Chrisostome, Nicolas Leymarie, Jean-Rémi Garbay, Françoise Rimareix, Chafika Mazouni
Publikováno v:
Breast Care. 11:128-132
Objective: We aimed at examining the potential benefits of blue dye in sentinel node biopsy (SNB) in comparison with its proven drawbacks. Patients and Methods: In 2007, 203 T1 primary breast carcinomas had been operated on in our institute. The pati
Autor:
Anthony Gonçalves, Richard Villet, Laura Sabiani, Emile Daraï, P.-E. Colombo, Alexandre de Nonneville, Charles Coutant, Nicolas Chopin, Sylvia Giard, Fabien Reyal, Christophe Scherer, Roman Rouzier, Xavier Muracciole, Eric Lambaudie, Christophe Zemmour, Monique Cohen, Renaud Sabatier, Jean Marie Boher, Jean Rémi Garbay, Pierre Gimbergues, Gilles Houvenaeghel, François Bertucci, Jean Marc Classe
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Breast Cancer Research and Treatment, Springer Verlag, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Benefit of adjuvant trastuzumab-based chemotherapy for node-positive and/or1 cm human epidermal growth factor receptor 2-positive (HER2+) breast carcinomas has been clearly demonstrated in randomized clinical trials. Yet, evidence that adjuvant chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52707bebec92efc50af588bef69c2935
https://hal-amu.archives-ouvertes.fr/hal-03623719
https://hal-amu.archives-ouvertes.fr/hal-03623719
Autor:
Pascal Bonnier, Jean-Rémi Garbay, Raoul Payan, Marie Bannier, Frederique Marchal, Jocelyne Jacquemier, Hervé Mignotte, Jean-Marc Classe, Jérôme Blanchot, Monique Cohen, Philippe Rouanet, Christine Tunon de Lara, Sandrine Fournet, Benjamin Esterni, Claude Nos, Gilles Houvenaeghel, Aubert Agostini, C. Belichard, Marc Martino, Sylvia Giard, Frédérique Penault-Llorca
Publikováno v:
Breast
Breast, Elsevier, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Breast, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Breast, Elsevier, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Breast, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
International audience; PURPOSE: The risk of non sentinel node (NSN) involvement varies in function of the characteristics of sentinel nodes (SN) and primary tumor. Our aim was to determine and validate a statistical tool (a nomogram) able to predict
Autor:
Lluis M. Mir, Poul F. Geertsen, C. Collins, Z Rudolf, Caroline Robert, Jean Rémi Garbay, Snezna M. Paulin-Kosir, Julie Gehl, Valérie Billard, Nassim Morsli, Damijan Miklavčič, Marko Snoj, Declan M. Soden, J. Larkin, Ivan Pavlović, Gregor Sersa, Michel Marty, Maja Cemazar, Gerald C. O'Sullivan
Publikováno v:
European Journal of Cancer Supplements. 4:3-13
Purpose: To evaluate and confirm efficacy and safety of electrochemotherapy with bleomycin or cisplatin on cutaneous and subcutaneous tumour nodules of patients with malignant melanoma and other malignancies in a multicenter study. Patients and metho
Autor:
Lluis M. Mir, Claire Bernat, Valérie Billard, Jean-Rémi Garbay, Caroline Robert, Nassim Morsli
Publikováno v:
European Journal of Cancer Supplements. 4:29-31
We report the successful treatment of a 66-year-old man with failure of conventional local and general treatments for Kaposi sarcoma. He had a poor quality of life because of large ulcerated lesions on both legs. After the first electrochemotherapy s
Autor:
Catherine Uzan, Jean-Rémi Garbay, C. Bezu, Emile Daraï, Emmanuelle Boutmy-Deslandes, Sarah Zohar, Chafika Mazouni, Roman Rouzier, Elisabeth Chereau
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0156096. 〈10.1371/journal.pone.0156096〉
PLoS ONE, 2016, 11 (6), pp.e0156096. ⟨10.1371/journal.pone.0156096⟩
PLoS ONE, Vol 11, Iss 6, p e0156096 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0156096. ⟨10.1371/journal.pone.0156096⟩
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0156096. 〈10.1371/journal.pone.0156096〉
PLoS ONE, 2016, 11 (6), pp.e0156096. ⟨10.1371/journal.pone.0156096⟩
PLoS ONE, Vol 11, Iss 6, p e0156096 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0156096. ⟨10.1371/journal.pone.0156096⟩
Objective The aim of this study was to assess the efficacy (response rate centered on 80%) of a somatostatin analog with high affinity for 4 somatostatin receptors in reducing the postoperative incidence of symptomatic lymphocele formation following